BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26507217)

  • 1. Evolving P450pyr Monooxygenase for Regio- and Stereoselective Hydroxylations.
    Yang Y; Li Z
    Chimia (Aarau); 2015; 69(3):136-41. PubMed ID: 26507217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of p450pyr hydroxylase for the highly regio- and enantioselective subterminal hydroxylation of alkanes.
    Yang Y; Liu J; Li Z
    Angew Chem Int Ed Engl; 2014 Mar; 53(12):3120-4. PubMed ID: 24554642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of recombinant E. coli cells co-expressing P450pyrTM monooxygenase and glucose dehydrogenase for highly regio- and stereoselective hydroxylation of alicycles with cofactor recycling.
    Pham SQ; Gao P; Li Z
    Biotechnol Bioeng; 2013 Feb; 110(2):363-73. PubMed ID: 22886996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving P450pyr monooxygenase for highly regioselective terminal hydroxylation of n-butanol to 1,4-butanediol.
    Yang Y; Chi YT; Toh HH; Li Z
    Chem Commun (Camb); 2015 Jan; 51(5):914-7. PubMed ID: 25435422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inverting the enantioselectivity of P450pyr monooxygenase by directed evolution.
    Tang WL; Li Z; Zhao H
    Chem Commun (Camb); 2010 Aug; 46(30):5461-3. PubMed ID: 20520890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving P450pyr hydroxylase for highly enantioselective hydroxylation at non-activated carbon atom.
    Pham SQ; Pompidor G; Liu J; Li XD; Li Z
    Chem Commun (Camb); 2012 May; 48(38):4618-20. PubMed ID: 22430002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
    Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
    J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving regio- and enantioselectivity of P450-catalyzed oxidative CH activation of small functionalized molecules by structure-guided directed evolution.
    Agudo R; Roiban GD; Reetz MT
    Chembiochem; 2012 Jul; 13(10):1465-73. PubMed ID: 22711296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regio- and stereoselectivity of P450-catalysed hydroxylation of steroids controlled by laboratory evolution.
    Kille S; Zilly FE; Acevedo JP; Reetz MT
    Nat Chem; 2011 Aug; 3(9):738-43. PubMed ID: 21860465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of (R)- and (S)-N-protected 3-hydroxypyrrolidines by hydroxylation with Sphingomonas sp. HXN-200, a highly active, regio- and stereoselective, and easy to handle biocatalyst.
    Li Z; Feiten HJ; Chang D; Duetz WA; van Beilen JB; Witholt B
    J Org Chem; 2001 Dec; 66(25):8424-30. PubMed ID: 11735520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
    Peters MW; Meinhold P; Glieder A; Arnold FH
    J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regioselectivity-driven evolution of CYP102D1 for improved synthesis of 3'-ortho-dihydroxyisoflavone.
    Choi KY; Yang YH; Kim BG
    Enzyme Microb Technol; 2015 Apr; 71():20-7. PubMed ID: 25765306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
    Roiban GD; Agudo R; Reetz MT
    Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered P450pyr monooxygenase for asymmetric epoxidation of alkenes with unique and high enantioselectivity.
    Li A; Liu J; Pham SQ; Li Z
    Chem Commun (Camb); 2013 Dec; 49(98):11572-4. PubMed ID: 24177733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
    Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
    J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CH-activating oxidative hydroxylation of 1-tetralones and related compounds with high regio- and stereoselectivity.
    Roiban GD; Agudo R; Ilie A; Lonsdale R; Reetz MT
    Chem Commun (Camb); 2014 Nov; 50(92):14310-3. PubMed ID: 25168091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the toolbox of organic chemists: directed evolution of P450 monooxygenases as catalysts in regio- and stereoselective oxidative hydroxylation.
    Roiban GD; Reetz MT
    Chem Commun (Camb); 2015 Feb; 51(12):2208-24. PubMed ID: 25483552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enantioselective Benzylic Hydroxylation Catalysed by P450 Monooxygenases: Characterisation of a P450cam Mutant Library and Molecular Modelling.
    Eichler A; Gricman Ł; Herter S; Kelly PP; Turner NJ; Pleiss J; Flitsch SL
    Chembiochem; 2016 Mar; 17(5):426-32. PubMed ID: 26698167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution.
    Pengpai Z; Sheng H; Lehe M; Yinlin L; Zhihua J; Guixiang H
    Appl Biochem Biotechnol; 2013 Sep; 171(1):93-103. PubMed ID: 23817788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of (S)-N-substituted 4-hydroxy-pyrrolidin-2-ones by regio- and stereoselective hydroxylation with Sphingomonas sp. HXN-200.
    Chang D; Witholt B; Li Z
    Org Lett; 2000 Nov; 2(24):3949-52. PubMed ID: 11101461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.